KING'S COLLEGE LONDON – MIA(IMP) 14523
| Authorisation Number | UK MIA(IMP) 14523 |
| Category | MIA(IMP) |
| Holder | KING'S COLLEGE LONDON |
| Registered Address | KING'S COLLEGE LONDON, DEPARTMENT OF HAEMATOLOGY & MOLECULAR MEDICINE, THE RAYNE INSTITUTE KING'S COLLEGE HOSPITAL AND KINGS COLLEGE, 123 COLDHARBOUR LANE, LONDON, SE5 9NU, UNITED KINGDOM |
| Authorisation Date | Jun 18, 2025 |
| Legal Basis | InvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031] |
| Sites | 2 |
| Manufacturing Operations | 1.1 1.1.1 1.1.1.4 1.1.1.6 1.1.3 1.3 1.3.1 1.3.1.1 1.3.1.2 1.3.1.3 1.3.1.4 1.3.1.5 1.3.1.6 1.3.1.8 1.3.2 1.3.2.1 1.3.2.2 1.3.2.3 1.3.2.4 1.3.2.5 1.3.2.6 1.3.2.8 1.4 1.4.2 1.4.2.1 1.5 1.5.2 1.6 1.6.2 1.6.3 1.6.4 |
| Importation Operations | 2.2 2.2.1 2.2.1.1 2.2.3 2.2.3.1 2.2.3.2 2.2.3.3 2.2.3.4 2.2.3.5 2.2.3.6 2.2.3.8 2.3 2.3.2 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (2)
KING'S COLLEGE LONDON - KING'S CTU, NIHR-WELLCOME TRUST CLINICAL RESEARCH FACILITY
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.4 — Small volume liquids
1.1.1.6 — Other aseptically prepared products
1.1.3 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.1 — Blood products
1.3.1.2 — Immunological products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.5 — Biotechnology products
1.3.1.6 — Human or animal extracted products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.1 — Blood products
1.3.2.2 — Immunological products
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.5 — Biotechnology products
1.3.2.6 — Human or animal extracted products
1.3.2.8 — Other biological medicinal products
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.5 — Packaging
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Importation
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.3 — Biological medicinal products
2.2.3.1 — Blood products
2.2.3.2 — Immunological products
2.2.3.3 — Cell therapy products
2.2.3.4 — Gene therapy products
2.2.3.5 — Biotechnology products
2.2.3.6 — Human or animal extracted products
2.3 — Other Importation Activities
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
RAYNE CELL THERAPY SUITE (RCTS), THE RAYNE INSTITUTE, KING'S COLLEGE HOSPITAL & KING'S COLLEGE LONDON
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.4 — Small volume liquids
1.1.3 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.1 — Blood products
1.3.1.2 — Immunological products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.5 — Biotechnology products
1.3.1.6 — Human or animal extracted products
1.3.2 — Batch certification
1.3.2.1 — Blood products
1.3.2.2 — Immunological products
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.5 — Biotechnology products
1.3.2.6 — Human or animal extracted products
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.5 — Packaging
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Importation
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.3 — Biological medicinal products
2.2.3.1 — Blood products
2.2.3.2 — Immunological products
2.2.3.3 — Cell therapy products
2.2.3.4 — Gene therapy products
2.2.3.5 — Biotechnology products
2.2.3.6 — Human or animal extracted products
2.2.3.8 — Other biological medicinal products
2.3 — Other Importation Activities
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
Content Preview
The source document is available on KeyPedia. Sign in to view.